Sarinthorn RakmaneeSamart PakakasamaSuradej HongengSirima SanguansinAcharawan ThongmeeWanida PongstapornRangsit UniversityMahidol University2018-12-212019-03-142018-12-212019-03-142017-04-01Asian Pacific Journal of Cancer Prevention. Vol.18, No.4 (2017), 1117-11202476762X151373682-s2.0-85019628742https://repository.li.mahidol.ac.th/handle/20.500.14594/41935Objectives: This study assessed associations of the miR196a2 (rs11614913) T > C polymorphism withsusceptibility to childhood acute lymphoblastic leukemia (ALL) and clinical outcomes. Materials and Methods: Blood DNA samples from 104 childhood ALL patients and 180 healthy children were studied for the miR-196a2 (rs11614913) polymorphism using a polymerase chain reaction-restriction fragment-length polymorphism (PCR-RFLP) approach. Results: The frequency of the miR-196a2 (rs11614913) T allele in controls was 0.51 compared with 0.33 in ALL cases. In this study, CC, TC heterozygote and CC/TC genotypes were significantly associated with increase childhood ALL susceptibility compared with the TT wild type (OR =4.321, 95% CI = 2.091-8.930 p=0.000, OR = 2.248, 95% CI =1.103-4.579, p=0.024, OR = 2.921, 95% CI = 1.504-5.673 p=0.001, respectively). However, the miR-196a2 (rs11614913) T > C polymorphism was not associated with demographic data or clinico-pathological data in ALL cases. Conclusion: CC, TC and CC+TC genotypes of miR-196a2 (rs11614913) was significantly associated with increased susceptibility in Thai childhood ALL but not with clinical variables.Mahidol UniversityBiochemistry, Genetics and Molecular BiologyArticleSCOPUS10.22034/APJCP.2017.18.4.1117